Nektar Therapeutics
NKTR
#5780
Rank
S$1.43 B
Marketcap
S$70.64
Share price
7.00%
Change (1 day)
245.85%
Change (1 year)

Earnings for Nektar Therapeutics (NKTR)

Earnings in 2025 (TTM): -S$0.15 Billion

According to Nektar Therapeutics 's latest financial reports the company's current earnings are S$62.6 Million. In 2024 the company made an earning of -S$0.16 Billion, an increase over its 2023 earnings that were of -S$0.36 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nektar Therapeutics from 1994 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$0.15 Billion-3.85%
2024 -S$0.16 Billion-56.85%
2023 -S$0.36 Billion-24.31%
2022 -S$0.48 Billion-30.25%
2021 -S$0.68 Billion17.87%
2020 -S$0.58 Billion0.88%
2019 -S$0.57 Billion-164.46%
2018 S$0.88 B-810.61%
2017 -S$0.13 Billion-37.06%
2016 -S$0.2 Billion89.22%
2015 -S$0.11 Billion48.22%
2014 -S$70.29 Million-65.93%
2013 -S$0.21 Billion-6.81%
2012 -S$0.23 Billion28.95%
2011 -S$0.18 Billion258.8%
2010 -S$47.86 Million-63.94%
2009 -S$0.14 Billion-392.45%
2008 S$45.38 M-211.74%
2007 -S$40.62 Million-79.57%
2006 -S$0.2 Billion-16.9%
2005 -S$0.24 Billion81.53%
2004 -S$0.14 Billion54.19%
2003 -S$85.48 Million-33.87%
2002 -S$0.13 Billion-9.6%
2001 -S$0.15 Billion73.39%
2000 -S$82.46 Million108.9%
1999 -S$39.48 Million39.48%
1998 -S$28.3 Million60.02%
1997 -S$17.69 Million18.05%
1996 -S$14.99 Million31.82%
1995 -S$11.37 Million57.14%
1994 -S$7.24 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
S$10.64 B-7,345.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$15.30 B-10,516.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$29.81 B-20,393.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Richardson Electronics
RELL
S$0.19 M-100.13%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$16.90 B-11,604.35%๐Ÿ‡ฌ๐Ÿ‡ง UK
Baxter
BAX
-S$0.35 Billion 137.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
S$0.52 B-456.48%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Johnson & Johnson
JNJ
S$41.83 B-28,571.74%๐Ÿ‡บ๐Ÿ‡ธ USA